Search Results 81-90 of 16907 for Ulcerative+colitis
Evaluation of the Relationship Between Pouch Function and Pouch Inflammation in Patients with Ulcerative Colitis · Overview · Participation eligibility.
The purpose of this study is to determine the long-term safety of vedolizumab intravenous (IV) treatment in pediatric participants with Ulcerative Colitis (UC) ...
... ulcerative colitis (UC) who are refractory to or intolerant of TNF inhibitors. Participation eligibility. Participant eligibility includes age, gender, type ...
... Ulcerative Colitis. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview.
... ulcerative colitis, which was first diagnosed in 1997. Scott had previously described his reasons for being public about his medical condition in this post ...
The study proposes to assess whether compared to placebo, CP-690,550 is effective, safe, and tolerable maintenance therapy in subjects with Ulcerative Colitis ( ...
... ulcerative colitis (UC). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...
Dorin T. Colibaseanu, M.D.. Colon and Rectal Surgeon. Jacksonville, FL. Areas of focus: Neuroendocrine tumor, Ulcerative colitis, Inflammatory bowel disease ...
This study is designed to evaluate the efficacy and safety of tofacitinib (CP-690,550) in patients with moderate to severe ulcerative colitis who have failed or ...
Budesonide rectal foam is used to help get mild to moderate active ulcerative colitis that extends from the rectum to the sigmoid colon under control (induce ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Their crucial work saves lives every day. Let Mayo Clinic researchers know they’re appreciated with a quick message.